KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.41 $2.35 Friday, 26th Apr 2024 CYCC stock ended at $1.51. This is 5.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.85% from a day low at $1.46 to a day high of $1.56.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Apr 12, 2016 $5.40 $5.40 $4.92 $4.92 9 648
Apr 11, 2016 $5.04 $5.28 $5.04 $5.28 6 922
Apr 08, 2016 $4.82 $5.16 $4.80 $5.04 3 606
Apr 07, 2016 $4.80 $5.28 $4.80 $4.92 5 195
Apr 06, 2016 $4.87 $5.16 $4.56 $4.93 10 692
Apr 05, 2016 $4.80 $4.86 $4.68 $4.76 2 594
Apr 04, 2016 $4.92 $4.92 $4.68 $4.80 1 450
Apr 01, 2016 $4.56 $4.80 $4.56 $4.68 2 172
Mar 31, 2016 $4.67 $4.91 $4.62 $4.62 4 505
Mar 30, 2016 $4.80 $5.03 $4.39 $4.70 1 463
Mar 29, 2016 $4.92 $5.04 $4.32 $4.68 8 808
Mar 28, 2016 $5.40 $5.40 $4.92 $4.92 5 758
Mar 24, 2016 $4.92 $5.40 $4.92 $5.16 6 592
Mar 23, 2016 $5.40 $5.40 $4.92 $4.92 5 375
Mar 22, 2016 $5.28 $5.52 $5.16 $5.40 3 667
Mar 21, 2016 $5.52 $5.64 $4.92 $5.16 7 017
Mar 18, 2016 $5.28 $5.64 $5.04 $5.04 7 592
Mar 17, 2016 $5.04 $5.28 $4.92 $5.16 7 033
Mar 16, 2016 $5.64 $5.64 $4.80 $5.28 7 017
Mar 15, 2016 $5.40 $5.88 $5.28 $5.64 37 083
Mar 14, 2016 $5.28 $5.40 $4.80 $5.28 1 433
Mar 11, 2016 $5.40 $5.40 $5.04 $5.28 2 550
Mar 10, 2016 $5.76 $5.88 $5.16 $5.40 6 025
Mar 09, 2016 $5.76 $6.12 $5.16 $5.64 4 200
Mar 08, 2016 $5.64 $5.88 $5.52 $5.64 7 275
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT